Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.12675
Abstract: Whether somatostatin analogs for acromegaly improve or worsen a patient's glycemic profile is controversial. A risk of hypoglycemia should be presumed, especially when patients receive insulin therapy, as the package inserts caution. However, a detailed… read more here.
Keywords: insulin; administration; glycemic profile; case ... See more keywords